Skip to main content
PeptiDex
  • Library
  • Stacks
  • Tools
  • Vendors
  • Blog
  • About
Start
§ Stay Current

The Peptide Brief.

Bi-weekly research updates, vendor news, and editorial analysis. No spam.

No spam. Unsubscribe anytime. We respect your inbox.

PeptiDex

The independent, evidence-based peptide research index. Trusted by researchers worldwide for unbiased education and verified sourcing.

§ Learn

  • Peptide 101
  • Library
  • Evidence Dashboard
  • Blog
  • FAQ

§ Tools

  • Cycle Planner
  • Evidence Dashboard
  • Peptide Comparison
  • Price Comparison
  • Reconstitution Calc
  • COA Analyzer

§ Source

  • Vendor Reviews
  • Amino Club Review
  • COA Library
  • Peptide Stacks

§ About

  • Our Mission
  • Editorial Policy
  • Medical Disclaimer
  • Contact
Last reviewed: May 4, 2026 · PeptiDex Editorial Team
© 2026 PeptiDex. All rights reserved.
PrivacyTermsDisclosures
All Blends
🛡️

Thymosin Alpha-1 / BPC-157

"The Immune Fortress"

Thymosin Alpha-1BPC-157Immune Support

Benefits

Enhanced immunity, faster illness recovery, gut-immune axis support

Why This Blend?

Thymosin Alpha-1 supercharges immune cell function (T-cells, NK cells, dendritic cells), while BPC-157 heals the gut lining where 70% of the immune system resides. Attacking immune weakness from both sides.

Mechanism of Action

Tα1 enhances T-cell maturation, NK cell activity, and dendritic cell function for improved pathogen response. BPC-157 repairs gut mucosal integrity, supporting the gut-associated lymphoid tissue (GALT) — the body's largest immune organ.

Dosing Protocol

Typical Ratio: Thymosin Alpha-1 1.6mg + BPC-157 500mcg

Tα1 1.6mg SubQ 2x/week + BPC-157 250-500mcg SubQ daily. Cycle 8-24 weeks. Ideal during cold/flu season or post-illness.

Expected Timeline

Week 1

Immune activation; NK cell and T-cell enhancement begins

Weeks 2–4

Improved immune response; gut healing supports immune function

Months 2–3

Sustained immune modulation; reduced frequency of illness

Long-term

Long-term immune resilience; gut-immune axis restoration

Supporting Studies

Thymosin Alpha-1 safety and efficacy review

Review of 30+ clinical trials with 11,000+ subjects confirming safety and efficacy.

strong

BPC-157 gastrointestinal healing

BPC-157 heals GI ulcers and inflammatory bowel lesions.

preclinical

Safety Notes

Thymosin Alpha-1 approved in 35+ countries. Both peptides well-tolerated. Excellent safety profiles.

📚 Individual Peptide Profiles

Thymosin Alpha-1 →BPC-157 →